Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
BMC Research Notes|February 11, 2016
Development of safe, effective and immunogenic vaccine candidate for diarrheagenic Escherichia coli main pathotypes in a mouse modelAsmaa Gohar, Nourtan F Abdeltawab, Ali Fahmy, et al.
Papillomavirus Research (Amsterdam, Netherlands)|June 12, 2019
Preclinical study of safety and immunogenicity of combined rubella and human papillomavirus vaccines: Towards enhancing vaccination uptake rates in developing countriesAsmaa Gohar, Nourtan F Abdeltawab, Nahla Shehata, et al.
Advances in Experimental Medicine and Biology|August 29, 2022
Heat Shock Proteins: Central Players in Oncological and Immuno-Oncological TracksRana A Youness, Asmaa Gohar, Caroline Joseph Kiriacos, et al.
Microbial Pathogenesis|September 5, 2022
Combination therapy between prophylactic and therapeutic human papillomavirus (HPV) vaccines with special emphasis on implementation of nanotechnologyAsmaa Gohar, Aya A Ali, Walid F Elkhatib, et al.
Molecular Biomedicine|October 10, 2024
Monoclonal antibodies: From magic bullet to precision weaponHassan Aboul-Ella, Asmaa Gohar, Aya Ahmed Ali, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 18, 2024
Alirocumab boosts antioxidant status and halts inflammation in rat model of sepsis-induced nephrotoxicity via modulation of Nrf2/HO-1, PCSK9/HMGB1/NF-ᴋB/NLRP3 and Fractalkine/CX3CR1 hubsNoha F Hassan, Mona R El-Ansary, Heba Mohammed Refat M Selim, et al.
Pageof 1